Please provide your email address to receive an email when new articles are posted on . The Apollo TMS device was previously FDA cleared for treating MDD in adults. TMS offers a non-pharmacologic ...
Munich, Germany; Atlanta, Georgia - September 10, 2025 – neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance, today announced it has ...
Medicare only covers transcranial magnetic stimulation (TMS) therapy for the treatment of severe major depressive disorder (MDD). Medicare covers daily outpatient TMS therapy for up to 6 weeks when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results